Moreover, WSB2 is a novel p53 destabilizer that promotes the polyubiquitination of K48-conjugated p53 at the Lys291 and Lys292 sites in HCC cells, leading to p53 proteasomal degradation (Li et al., 2024). The gene discussed is WSB2; the disease is hepatocellular carcinoma.